GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Dynatronics Corp (NAS:DYNT) » Definitions » Cash Conversion Cycle

Dynatronics (Dynatronics) Cash Conversion Cycle : 86.15 (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Dynatronics Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Dynatronics's Days Sales Outstanding for the three months ended in Dec. 2023 was 44.77.
Dynatronics's Days Inventory for the three months ended in Dec. 2023 was 97.94.
Dynatronics's Days Payable for the three months ended in Dec. 2023 was 56.56.
Therefore, Dynatronics's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2023 was 86.15.


Dynatronics Cash Conversion Cycle Historical Data

The historical data trend for Dynatronics's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dynatronics Cash Conversion Cycle Chart

Dynatronics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 108.21 103.77 82.82 92.63 93.65

Dynatronics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 101.51 100.87 84.34 76.74 86.15

Competitive Comparison of Dynatronics's Cash Conversion Cycle

For the Medical Devices subindustry, Dynatronics's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dynatronics's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Dynatronics's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Dynatronics's Cash Conversion Cycle falls into.



Dynatronics Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Dynatronics's Cash Conversion Cycle for the fiscal year that ended in Jun. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=41.07+116.68-64.1
=93.65

Dynatronics's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=44.77+97.94-56.56
=86.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dynatronics  (NAS:DYNT) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Dynatronics Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Dynatronics's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Dynatronics (Dynatronics) Business Description

Traded in Other Exchanges
N/A
Address
1200 Trapp Road, Eagan, MN, USA, 55121
Dynatronics Corp is a United States-based company that is engaged in designing, manufacturing, and distributing advanced-technology medical devices, therapeutic and medical treatment tables, rehabilitation equipment, custom athletic training treatment tables and equipment, institutional cabinetry as well as other rehabilitation and therapy products and supplies. The company markets and sells its products to physical therapists, chiropractors, athletic trainers, sports medicine practitioners, and other medical professionals and institutions. It offers customers a one-stop-shop for their medical equipment and supply needs, including electrotherapy, therapeutic ultrasound, phototherapy, rehabilitation products, treatment tables, customized training room products, and exercise products.
Executives
Gabriel Ellwein officer: Chief Financial Officer 4782 HIGHCROFT COURT, EAGAN MN 55122
John Anthony Krier director, officer: Chief Executive Officer 319 WEST 50TH SOUTH, MINNEAPOLIS MN 55419
David B Holtz director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Scott Klosterman director
R Scott Ward director 1064 S. CRESTVIEW CIRCLE, SLC VA 84108
Stuart Essig 10 percent owner 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Erin S. Enright director 666 PLAINSBORO ROAD, PLAINSBORO NJ 08536
Brian Larkin director INTEGRA LIFESCIENCES CORPORATION, 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Brian D. Baker officer: Chief Operating Officer C/O SEASPINE HOLDINGS CORPORATION, 2302 LA MIRADA DRIVE, VISTA CA 92081
Provco Ventures 1 Lp 10 percent owner 795 E LANCASTER AVE SUITE 200, VILLANOVA PA 19085
Norman Iii Roegner officer: Chief Financial Officer 1200 TRAPP ROAD, EAGAN MN 55121
Skyler N Black officer: Corporate Controller 1448 E LEXI LN, COTTONWOOD HEIGHTS UT 84093
Keeler Jennifer Bennett Bennett officer: Secretary / General Counsel 8620 STILLWATER BLVD N, LAKE ELMO MN 55042
Daryl Connell officer: Chief Information Officer 932 MINJON DRIVE, APPLE VALLEY MN 55124
Cynthia L. Mchenry officer: VP, Operations 7030 PARK CENTRE DRIVE, COTTONWOOD HEIGHTS UT 84121